A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China

International Journal of Epidemiology

Volumn 27, Issue 4, 1998, Pages 574-578

  Zhang, Jian Ying ^a,b   Dai, Min ^a   Wang, Xiao ^a   Lu, Wei Quan ^a   Li, Dong Sheng ^a   Zhang, Mei Xi ^a   Wang, Ke Juan ^a   Dai, Li Ping ^a   Han, Sheng Gao ^a   Zhou, Yuan Fang ^a   Zhuang, Hui ^c  

^a ZHENGZHOU UNIVERSITY   (China)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Case control study; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Prevalence; Risk factor

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

HEALTH RISK; HEPATITIS; INFECTIOUS DISEASE; RISK FACTOR;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL PATIENT; HUMAN; INTERVIEW; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR;

ASIA; BIOLOGY; CANCER; CHINA; DEVELOPING COUNTRIES; DISEASES; EASTERN ASIA; HEPATITIS; LIVER NEOPLASMS; MEASUREMENT; NEOPLASMS; PREVALENCE; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; VIRAL DISEASES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

CHINA;

EID: 0031658280     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.4.574     Document Type: Article

References (23)

1. Parkin D, Pisani P, Ferlay J, Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Simonetti RG, Carnma C, Fiorello F, Politi F, Pamico G, Pagliaro L. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Digest Dis Sci 1991;36:962-72.
3. Yen FS, Sheri KN. Epidemiology and early diagnosis of primary liver Cancer in China. Adv Cancer Res 1986;47:297-329.
4. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-75.
5. Shimotohno K. Hepatitis C virus as a causative agent of heptocellular carcinoma. Intervirology 1995;38:162-69.
6. Beasley RP. Hepatitis B virus, the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
7. Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Trichopoulos D. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 1995;60:627-31
8. Vail Mayans M, Calvet X, Bruix J et al. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 1990;46:378-81.
9. Filipazzo MG, Aragoma E, Cottone M, Dardanoni G, Lanlarone F, Pagliaro L. Assessment of some risk factors for hepatocellular car- cinoma: a case control study, Stat Med 1985;4:345-51.
10. Di Bisceglie AM, Order SE, Klein JL et al. The role of chronic virus hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991;86:335-38.
11. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Nishino N. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-47.
12. Tsai JF, Chang WY, Jeng JE, Ho MS, Un ZY, Tsai JH. Hepatitis B and G virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994;14:98-102.
13. Zhang JY. The research progress of the relationship between hepatitis B, C infection and hepatocellular carcinoma, In: Zhang JY, Zheng PY, Zhang Y (eds). Research and Practice in Viral Liver Diseases. Chinese Science and Technology Press, 1995, pp. 148-67.
14. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
15. Colombo M, Kuo G, Choo QL, Donate MF, Del Ninno E, Tommasini MA. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;ii:1006-09.
16. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in Southern African blacks with hepatocellular carcinoma. Lancet 1990;i:873-74.
17. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-41.
18. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-33.
19. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-55.
20. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351: 317-20.
21. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC, Hepatitis B virus X protein inhibits P53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994:91:2230-34.
22. Linnen J, Wanges JJ, Zhang-keck, ZY. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-08.
23. James DG. Viral hepatitis G string. Q J Med 1996;89:159-60